المؤلفون: D. Voieikova, L. Stepanova, O. Savchuk, L. Ostapchenko, M. Kondro

المصدر: Vìsnik: Kiïvsʹkij Nacìonalʹnij Unìversitet Imenì Tarasa Ševčenka. Bìologìâ, Vol 70, Iss 2, Pp 81-84 (2016)

مصطلحات موضوعية: glutamate-induced obesity, cerium dioxide, pioglitazone, protein fractions, hepatocytes, Biology (General), QH301-705.5

وصف الملف: electronic resource

Relation: http://biovestnik.com/index.php/biology/article/view/63; https://doaj.org/toc/1728-2748; https://doaj.org/toc/2308-8036

URL الوصول: https://doaj.org/article/0719788ab9e04d8caa1c8d828b810240

المؤلفون: Stepan S. Korotkiy, Olga A. Saltykova, Andrey O. Ukharov, Irena L. Shlivko, Irina A. Klemenova, Oxana E. Garanina, Kseniia A. Uskova, Anna M. Myronycheva, Yana L. Stepanova

المصدر: RUDN Journal of Engineering Research, Vol 24, Iss 3, Pp 262-270 (2023)

مصطلحات موضوعية: artificial intelligence, ai, neural network, smartphone application, skin cancer, skin self-examination, prorodinki, skinvision, skinive, risk assessment, Engineering (General). Civil engineering (General), TA1-2040

وصف الملف: electronic resource

Relation: https://journals.rudn.ru/engineering-researches/article/viewFile/37069/22839; https://doaj.org/toc/2312-8143; https://doaj.org/toc/2312-8151

URL الوصول: https://doaj.org/article/d83edbbe86ac4e3c90d4719ed08cadc2

المؤلفون: Elena L. Stepanova, Anatoly P. Ovchinnikov

المصدر: Вестник Иркутского государственного технического университета (2022)

مصطلحات موضوعية: Engineering (General). Civil engineering (General), TA1-2040, Transportation engineering, TA1001-1280

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1814-3520

URL الوصول: https://doaj.org/article/451c241e26c24918b2d3b622c9694459

المؤلفون: M. L. Stepanova, O. A. Kuznetsovа, P. S. Shilo, F. V. Moiseenko, N. Kh. Abduloeva, E. V. Artemyeva, A. S. Zhabina, M. M. Kramchaninov, N. M. Volkov, I. A. Pokataev, A. A. Rumyantsev, I. L. Plaksa, M. A. Gairyan, A. A. Isaev, M. V. Ivanov, Yu. F. Sadykova, V. A. Mileiko, V. V. Shamrikova, E. V. Ledin, A. A. Tryakin, M. Yu. Fedyanin, М. Л. Степанова, О. А. Кузнецова, П. С. Шило, Ф. В. Моисеенко, Н. Х. Абдулоева, Е. В. Артемьева, А. С. Жабина, М. М. Крамчанинов, Н. М. Волков, И. А. Покатаев, А. А. Румянцев, И. Л. Плакса, М. А. Гайрян, А. А. Исаев, М. В. Иванов, Ю. Ф. Садыкова, В. А. Милейко, В. В. Шамрикова, Е. В. Ледин, А. А. Трякин, М. Ю. Федянин

المصدر: Surgery and Oncology; Том 12, № 3 (2022); 26-35 ; Хирургия и онкология; Том 12, № 3 (2022); 26-35 ; 2949-5857

مصطلحات موضوعية: прецизионная онкология, FoundationOne® Medicine, precision oncology

وصف الملف: application/pdf

Relation: https://www.onco-surgery.info/jour/article/view/550/395; Berger M.F., Mardis E.R. the emerging clinical relevance of genomics in cancer medicine. Nat Rev Clin Oncol 2018;15(6):353–65. DOI:10.1038/s41571-018-0002-6; Hyman D.M., Taylor B.S., Baselga J. Implementing genome-driven oncology. Cell 2017;168:584–99.; Suh J.H., Johnson A., Albacker L. et al. Comprehensive genomic profiling facilitates implementation of the National Comprehensive Cancer Network Guidelines for lung cancer biomarker testing and identifies patients who may benefit from enrollment in mechanism-driven clinical trials. Oncologist 2016;21(6):684–91. DOI:10.1634/theoncologist.2016-0030; Rankin A., Klempner S.J., Erlich R. et al. Broad detection of alterations predicted to confer lack of benefit from EGFR antibodies or sensitivity to targeted therapy in advanced colorectal cancer. Oncologist 2016;21(11):1306–14.; Drilon A., Wang L., Arcila M.E. et al. Broad, hybrid capture-based next-generation sequencing identifies actionable genomic alterations in lung adenocarcinomas otherwise negative for such alterations by other genomic testing approaches. Clin Cancer Res 2015;21(16):3631–9. DOI:10.1158/1078-0432.CCR-14-2683; FoundationOne® CDx FDA Approval Press Release, 2017. Available at: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm587273.htm.; FoundationOne® CDx FDA Approval, 2017. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170019a.pdf.; Flaherty K.T., Gray R., Chen A. et al. the Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: lessons for genomic trial design. J Natl Cancer Inst 2020;112(10):1021–9.; Schneider B.P., Jiang G., Ballinger T. et al. a postneoadjuvant, randomized phase ii trial of personalized therapy versus treatment of physician’s choice for patients with residual triple-negative breast cancer. J Clin Oncol 2022;40(4):345–55. DOI:10.1200/JCO.21.01657; Институт клинических и лабораторных стандартов. H3-A6. Процедура сбора диагностических образцов крови путем венепункции. Утвержденный стандарт. 6-е издание.; Клинические рекомендации. Доступно по: https://oncology-association.ru/clinical-guidelines.; Sunami K., Ichikawa H., Kubo T. et al. Feasibility and utility of a panel testing for 114 cancer associated genes in a clinical setting: a hospital-based study. Cancer Sci 2019;110:1480–90.; Sicklick J.K., Kato S., Okamura R. et al. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. Nat Med 2019;25:744–50.; Rodon J., Soria J.-C., Berger R. et al. Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial. Nat Med 2019;25:751–8. DOI:10.1038/s41591-019-0424; Van der Velden D.L., Hoes L.R., van der Wijngaart H. et al. the Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs. Nature 2019;574(7776):127–31.; Rothwell D.G., Ayub M., Cook N. et al. Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study. Nat Med 2019;25(5):738–43.; Le Tourneau C., Delord J.-P., Gonçalves A. et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol 2015;16:1324–34.; Mangat P.K., Halabi S., Bruinooge S.S. et al. Rationale and design of the targeted agent and profiling utilization registry (TAPUR) study. JCO Precis Oncol 2018;2018:1. DOI:10.1200/PO.18.00122; Chen A.P., Williams M., Kummar S. et al. Feasibility of molecular profiling based assignment of cancer treatment (MPACT): a randomized NCI precision medicine study. JCO 2016;34:2539.; Trédan O., Wang Q., Pissaloux D. et al. Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: Analysis from the ProfiLER trial. Ann Oncol 2019;30:757–65.; Coyne G.O., Takebe N., Chen A.P. Defining precision: the precision medicine initiative trials NCI-MPACT and NCIMATCH. Curr Probl Cancer 2017;41(3):182–93.; NCI-MATCH Sets “Benchmark of Actionability”. Cancer Discov 2021;11(1):6, 7. DOI:10.1158/2159-8290.CD-NB2020-100; National Cancer Institute. Age and cancer risk. Available at: https://www.cancer.gov/about-cancer/causes-prevention/risk/age.; Hirshfield K.M., Tolkunov D., Zhong H. et al. Clinical action ability of comprehensive genomic profiling for management of rare or refractory cancers. Oncologist 2016;21:1315–25. DOI:10.1634/theoncologist.2016-0049; Hilal T., Nakazawa M., Hodskins J. et al. Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy. BMC Cancer 2017;17:602.; Johnson D.B., Dahlman K.H., Knol J. et al. Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel. Oncologist 2014;19:616–22.; Wheler J.J., Janku F., Naing A. et al. Cancer therapy directed by comprehensive genomic profiling: a single center study. Cancer Res 2016;76:3690–701. DOI:10.1158/0008-5472.CAN-15-3043; https://www.onco-surgery.info/jour/article/view/550

الاتاحة: https://www.onco-surgery.info/jour/article/view/550
https://doi.org/10.17650/2686-9594-2022-12-3-26-35

المؤلفون: Fedor V. Moiseenko, Mikhail Yu. Fedyanin, Nikita M. Volkov, Nuriniso Kh. Abduloeva, Natalya V. Levchenko, Vyacheslav A. Chubenko, Albina S. Zhabina, Maria L. Stepanova, Mikhail M. Kramchaninov, Elizaveta V. Artemeva, Vladimir M. Moiseyenko

المصدر: Alʹmanah Kliničeskoj Mediciny, Vol 50, Iss 1, Pp 47-55 (2022)

مصطلحات موضوعية: lung cancer, non-small cell lung cancer, medical treatment, clinical trials, Medicine

Relation: https://almclinmed.ru/jour/article/viewFile/1610/1438; https://doaj.org/toc/2072-0505; https://doaj.org/toc/2587-9294; https://doaj.org/article/8287edf3421a4498985c6a66a464a8e4

الاتاحة: https://doi.org/10.18786/2072-0505-2022-50-004
https://doaj.org/article/8287edf3421a4498985c6a66a464a8e4

المؤلفون: Tatyana N. Sokolova, Tatyana I. Solov'eva, Svetlana N. Aleksakhina, Grigorii A. Janus, Alla Goryainova, Mark I. Gluzman, Rashida V. Orlova, Anastasiya I. Stukan, Ruslan A. Zukov, Alena V. Zyuzyukina, Yulia N. Murunova, Aleksandr V. Sultanbaev, Elena N. Vorobeva, Leonid M. Mikhaevich, Victoria N. Pyliv, Anna N. Lysenko, Zarema K. Khachmamuk, Andrey E. Kozlov, Sergey Y. Bakharev, Shahen G. Parsyan, Elena I. Rossokha, Leri D. Osidze, Irina S. Shumskaya, Anna V. Agaeva, Tatiana A. Kasmynina, Veronika V. Klimenko, Kamila T. Akhmetgareeva, Almira A. Vakhitova, Madina D. Chakhkieva, Vadim N. Dmitriev, Yana I. Bakshun, Alexey E. Vasilyev, Dunya D. Gasimly, Nadezhda A. Kravchenko, Dmitriy A. Maksimov, Alfia I. Nesterova, Ineza O. Sharvashidze, Christina H. Gadzaova, Galina G. Rakhmankulova, Zaur M. Khamgokov, Irina K. Amirkhanova, Ludmila V. Bembeeva, Vladimir I. Vladimirov, Oleg L. Petrenko, Natalia G. Ruskova, Ekaterina L. Serikova, Ksenia S. Subbotina, Svetlana A. Tkachenko, Victor L. Chang, Sanal P. Erdniev, Victoria S. Barbara, Anna V. Vasilevskaya, Yulia V. Mikheeva, Nataliya O. Popova, Ekaterina P. Startseva, Anastasia V. Fateeva, Denis Y. Yukalchuk, Anna A. Grechkina, Khedi S. Musaeva, Svetlana V. Odintsova, Alena S. Stel'makh, Petimat I. Khabibulaeva, Alina G. Khlobystina, Kseniya A. Shvaiko, Elena A. Basova, Irina A. Bogomolova, Marina B. Bolieva, Viktor E. Goldberg, Marianna V. Kibisheva, Konstantin V. Menshikov, Dmitrii V. Ryazanov, Mariya L. Stepanova, Yana A. Udalova, Aleksandr V. Shkradyuk, Yana S. Chapko, Anna A. Shchukina, Idris M. Khabriev, Dmitrii V. Kirtbaya, Alexey M. Degtyarev, Aleksandr A. Epkhiev, Yana A. Tyugina, Mirza A. Murachuev, Aleksandr V. Togo, Aglaya G. Ievleva, Evgenii N. Imyanitov

المصدر: Современная онкология, Vol 24, Iss 1, Pp 12-23 (2022)

مصطلحات موضوعية: breast cancer, hr+/her2- breast cancer, breast cancer subtypes, pi3k, pik3ca, screening, alpelisib, clinical and morphological parameters of the tumor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

Relation: https://modernonco.orscience.ru/1815-1434/article/viewFile/106754/81166; https://doaj.org/toc/1815-1434; https://doaj.org/toc/1815-1442; https://doaj.org/article/ac2dc051d6cd4d1686520ce6a60f66af

الاتاحة: https://doi.org/10.26442/8151434.2022.1.201435
https://doaj.org/article/ac2dc051d6cd4d1686520ce6a60f66af

المؤلفون: R. A. Murashko, L. G. Teslenko, L. L. Stepanova, O. M. Golub, S. V. Sharov

المصدر: Инновационная медицина Кубани, Vol 6, Iss 2, Pp 60-67 (2019)

مصطلحات موضوعية: population-based cancer registries, malignancies, mean age of средний возраст primary diagnosed patients, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Diseases of the circulatory (Cardiovascular) system, RC666-701, Surgery, RD1-811, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9

وصف الملف: electronic resource

Relation: https://www.innovmedkub.ru/jour/article/view/74; https://doaj.org/toc/2541-9897

URL الوصول: https://doaj.org/article/d3752e42199d45829c166d2ce6738e5f

المؤلفون: M. A. Vishnyakova, T. G. Alexandrova, T. V. Buravtseva, M. O. Burlyaeva, G. P. Egorova, E. V. Semenova, I. V. Seferova, I. L. Stepanova, I. I. Yankov

المصدر: Труды по прикладной ботанике, генетике и селекции, Vol 179, Iss 3, Pp 23-38 (2019)

مصطلحات موضوعية: genetic resources of grain legumes, collection, mobilization, foreign material, diversity, requests, exchange, expeditions, wild species, Biotechnology, TP248.13-248.65, Botany, QK1-989

وصف الملف: electronic resource

Relation: https://elpub.vir.nw.ru/jour/article/view/277; https://doaj.org/toc/2227-8834; https://doaj.org/toc/2619-0982

URL الوصول: https://doaj.org/article/0d8afaf000b7435fa7c341cc9326485d

المؤلفون: R. A. Murashko, A. G. Baryshev, L. G. Teslenko, L. L. Stepanova, I. Yu. Lakomsky

المصدر: Кубанский научный медицинский вестник, Vol 25, Iss 2, Pp 115-120 (2018)

مصطلحات موضوعية: colorectal cancer, survival of patients, long-term results of treatment, Medicine

وصف الملف: electronic resource

Relation: https://ksma.elpub.ru/jour/article/view/1141; https://doaj.org/toc/1608-6228; https://doaj.org/toc/2541-9544

URL الوصول: https://doaj.org/article/2ba4f0e467324ce7a44e39ad17d31bdf

المؤلفون: S. V. Sharov, R. A. Murashko, L. G. Teslenko, L. L. Stepanova

المصدر: Кубанский научный медицинский вестник, Vol 25, Iss 2, Pp 140-148 (2018)

مصطلحات موضوعية: melanoma skin cancer, survival, early diagnosis, Medicine

وصف الملف: electronic resource

Relation: https://ksma.elpub.ru/jour/article/view/1145; https://doaj.org/toc/1608-6228; https://doaj.org/toc/2541-9544

URL الوصول: https://doaj.org/article/6f73e754a55546a69ece2d971f5a8094

المؤلفون: T. Yu. Semiglazova, E. V. Lubennikova, L. V. Bolotina, R. V. Orlova, F. V. Moiseenko, A. V. Avramenko, E. V. Artemeva, S. A. Borozdina, A. A. Vakhitova, N. M. Volkov, I. P. Ganshina, Sh. A. Dzhalilova, L. G. Zhukova, B. S. Kasparov, A. A. Kachmazov, V. V. Klimenko, A. i. Kornietskaya, A. A. Meshcheryakov, A. A. Paichadze, A. N. Poltoratsky, O. E. Ryabishina, M. L. Stepanova, E. N Imyanitov

المصدر: Медицинский совет, Vol 0, Iss 20, Pp 143-146 (2020)

مصطلحات موضوعية: metastatic breast cancer, brca mutation, parp inhibitors, talazoparib, objective response, disease control, progression-free survival, anemia, thrombocytopenia, Medicine

Relation: https://www.med-sovet.pro/jour/article/view/5937; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790; https://doaj.org/article/4dfe72bac118488ca84b9c829b2faa84

الاتاحة: https://doi.org/10.21518/2079-701X-2020-20-143-149
https://doaj.org/article/4dfe72bac118488ca84b9c829b2faa84

المؤلفون: I. A. Pokataev, M. A. Lyadova, М. Yu. Fedyanin, A. A. Tryakin, V. A. Chubenko, F. V. Moiseenko, L. A. Zagorskaya, М. L. Stepanova, A. V. Androsova, D. A. Nosov, N. V. Karpova, О. I. Kit, L. Yu. Vladimirova, I. L. Popova, A. V. Belonogov, D. М. Ponomarenko, D. Yu. Yukalchuk, V. Е. Shikina, N. V. Ivanova, А. I. Khasanova, А. D. Kruglov, I. Yu. Stradaeva, А. S. Perepletova, V. М. Filippova, N. L. Buzova, О. V. Khavaeva, Kh. S. Musaeva, А. Yu. Goryainova, О. V. Romanchuk, I. Sh. Tespizhek, S. А. Tyulyandin, И. А. Покатаев, М. А. Лядова, М. Ю. Федянин, А. А. Трякин, В. А. Чубенко, Ф. В. Моисеенко, Л. А. Загорская, М. Л. Степанова, А. В. Андросова, Д. А. Носов, Н. В. Карпова, О. И. Кит, Л. Ю. Владимирова, И. Л. Попова, А. В. Белоногов, Д. М. Пономаренко, Д. Ю. Юкальчук, В. Е. Шикина, Н. В. Иванова, А. И. Хасанова, А. Д. Круглов, И. Ю. Страдаева, А. С. Переплетова, В. М. Филиппова, Н. Л. Бузова, О. В. Хаваева, Х. С. Мусаева, А. Ю. Горяинова, О. В. Романчук, И. Ш. Теспижек, С. А. Тюляндин

المصدر: Malignant tumours; Том 9, № 3 (2019); 20-30 ; Злокачественные опухоли; Том 9, № 3 (2019); 20-30 ; 2587-6813 ; 2224-5057

مصطلحات موضوعية: химиотерапия, gemcitabine, nab-paclitaxel, chemotherapy, гемцитабин, nab-паклитаксел

وصف الملف: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/670/461; Von Hoff D.D. et al. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine // N. Engl. J. Med. 2013. Vol. 369, № 18. P. 1691-1703.; Tabernero J. et al. Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer // The Oncologist. 2015. Vol. 20, № 2. P. 143-150.; https://www.malignanttumors.org/jour/article/view/670

الاتاحة: https://www.malignanttumors.org/jour/article/view/670
https://doi.org/10.18027/2224-5057-2019-9-3-20-30

المؤلفون: I. A. Pokataev, M. A. Lyadova, M. Yu. Fedyanin, A. A. Tryakin, V. F. Chubenko, F. V. Moiseenko, L. A. Zagorskaya, M. L. Stepanova, A. V. Androsova, D. A. Nosov, N. V. Karpova, O. I. Kit, L. Yu. Vladimirova, I. L. Popova, A. V. Belonogov, D. M. Ponomarenko, D. Yu. Yukalchuk, V. E. Shikina, N. V. Ivanova, A. I. Khasanova, A. D. Kruglov, I. Yu. Stradaeva, A. S. Perepletova, V. M. Filippova, N. L. Buzova, O. V. Khavaneva, Kh. S. Musaeva, A. Yu. Goryainova, O. V. Romanchuk, I. Sh. Tespizhek, S. A. Tyulyandin

المصدر: Медицинский совет, Vol 0, Iss 19, Pp 74-82 (2019)

مصطلحات موضوعية: pancreatic cancer, gemcitabine, nab-paclitaxel, chemotherapy, Medicine

Relation: https://www.med-sovet.pro/jour/article/view/5190; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790; https://doaj.org/article/edea90a163bc42438bb0f9e0ef411a7b

الاتاحة: https://doi.org/10.21518/2079-701X-2019-19-74-82
https://doaj.org/article/edea90a163bc42438bb0f9e0ef411a7b

المؤلفون: L. Stepanova A., M. Shuklina A., E. Blokhina A., R. Kotlyarov Y., A. Kovaleva A., N. Ravin V., L. Tsybalova M., Л. Степанова А., М. Шуклина А., Е. Блохина А., Р. Котляров Ю., А. Ковалева А., Н. Равин В., Л. Цыбалова М.

المصدر: Journal Infectology; Том 9, № 4 (2017); 43-52 ; Журнал инфектологии; Том 9, № 4 (2017); 43-52 ; 2072-6732 ; 10.22625/2072-6732-2017-9-4

مصطلحات موضوعية: influenza virus, recombinant vaccine, M2e ectodomain, HA2, immune response, вирус гриппа, рекомбинантная вакцина, эктодомен белка М2, НА2, иммунитет

وصف الملف: application/pdf

Relation: https://journal.niidi.ru/jofin/article/view/655/577; Huleatt, J.W. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin / J.W. Huleatt [et al.] / Vaccine. – 2008. – Vol. 26. – P. 201–214.; Schotsaert, M. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments / M. Schotsaert [et al.] / Expert. Rev. Vaccines. – 2009. – Vol. 8. – P. 499–508.; Kim, M-C. Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus / M-C. Kim [et al.] / Molecular Therapy. – 2013. – Vol. 21. – P. 485–492.; Stepanova, L.A. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin / L.A. Stepanova [et al.] / PLoS One. – 2015. – Vol. 10. – e0119520.; Tsybalova, L.M. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e / L.M. Tsybalova [et al.] / Vaccine. – 2015. – Vol. 33. – P. 3398–3406.; Taylor, D.N. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI) / D.N. Taylor [et al.] / Vaccine. – 2011. – Vol. 29. – P. 4897–4902.; Turley, C.B. Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults / C.B. Turley [et al.] / Vaccine. – 2011. – Vol. 29. – P. 5145–5152.; Wang, T.T. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins / T.T. Wang [et al.] / PloS Pathog. – 2010. – Vol. 6. – P. e1000796.; Ekiert, D.C. A highly conserved neutralizing epitope on group 2 influenza A viruses / D.C. Ekiert [et al.] / Science. – 2011. – Vol. 333. – P. 843–850.; Wrammert, J. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. / J. Wrammert [et al.] / J. Exp. Med. – 2011. – Vol. 208. – P. 181–193.; Wang, T.T. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes / T.T. Wang [et al.] / Proc. Natl. Acad. Sci. U S A. – 2010. – Vol. 107. – P. 18979–18984.; Bommakanti, G. Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge / G. Bommakanti [et al.] / Proc. Natl. Acad. Sci. U S A. – 2010. – Vol. 107. – P. 13701–1376.; Ameghi, A. Protective immunity against homologous and heterologous influenza virus lethal challenge by immunization with new recombinant chimeric HA2-M2e fusion protein in balb/c mice / A. Ameghi [et al.] / Viral. Immunol. – 2016. – Vol. 29. – P. 228–234.; Stepanova, L.A. A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity / L.F. Stepanova [et al.] / Acta Naturae. – 2016. – Vol. 8. – P. 116–126.; Gong, X. Conserved stem fragment from H3 influenza hemagglutinin elicits cross-clade neutralizing antibodies through stalk-targeted blocking of conformational change during membrane fusion / X. Gong [et al.] / Immunol. Lett. – 2016. – Vol. 172. – P. 11–20.; Jegerlehner, A. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibodydependent NK cell activity / A. Jegerlehner [et al.] / J. Immunol. – 2004. – Vol. 172. – P. 5598–5605.; Feng, J. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2 / J. Feng [et al.] / Virol. J. – 2006. – Vol. 3. – P.102.; Khanna, M. Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine Development / M. Khanna [et al.] / BioMed. Res. Int. – 2014. – 2014:546274.; Honko, A.N. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis / A.N. Honko [et al.] / Infect. Immun. – 2006. – Vol. 74. – P. 1113–1120.; Bates, J.T. Mucosal adjuvant activity of flagellin in aged mice / J.T.Bates [et al.] / Mech. Ageing Dev. – 2008. – Vol. 129. – P. 271–281.; Liu, G. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections / G. Liu [et al.] / Vaccine. – 2012. – Vol. 30. – P. 6833–6838.; Katoh, K. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform/ K. Katon [et al.] / Nucleic Acids Res. – 2002. – Vol. 30. – P. 3059–3066.; Okonechnikov, K. Unipro UGENE: a unified bioinformatics toolkit / K. Okonechnikov [et al.] / Bioinformatics. – 2012. – Vol. 28. – P. 1166–1167.; Lee, Y.N. Mechanisms of cross-protection by influenza virus M2-based vaccines / Y.N. Lee [et al.] / Immune Netw. – 2015. – Vol. 15. – P. 213–221.; Swain, S.L. Expanding roles for CD4+ T cells in immunity to viruses / S.L. Swain, K.K. McKinstry, T.M. Strutt / Nat. Rev. Immunol. – 2012. – Vol. 12. – P. 136–148.; McKinstry, K.K. Memory CD4+ T cells protect against influenza through multiple synergizing mechanism / K.K. McKinstry [et al.] / J. Clin. Invest. – 2012. – Vol. 122. – P. 2847–2856.; Eliasson, D.G. M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection / D.G. Eliasson [et al.] / Mucosal Immunol. – 2017. – doi:10.1038/ mi.2017.14.; Sridhar, S. Cellular immune correlates of protection against symptomatic pandemic influenza / S. Sridhar [et al.] / Nat. Med. – 2013. – Vol. 19. – P. 1305–1312.; Zhou, L. Sudden increase in human infection with avian influenza A(H7N9) virus in China, Semptember- December 2016 / L. Zhou [et al.] / Western Pac. Surveill Response J. – 2017. – Vol. 8. – P. 1–9.; https://journal.niidi.ru/jofin/article/view/655

الاتاحة: https://journal.niidi.ru/jofin/article/view/655
https://doi.org/10.22625/2072-6732-2017-9-4-43-52

المؤلفون: Yimei Hou, L. Stepanova

المصدر: Research Notes. :76-81

مصطلحات موضوعية: Junior school, Complementary and alternative medicine, Process (engineering), Mathematics education, Pharmaceutical Science, Pharmacology (medical), Context (language use), Stage (hydrology), Music learning, Psychology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::baeedb621f035a68093f5453415a145c
https://doi.org/10.31654/2663-4902-2021-pp-2-76-81

المؤلفون: L. Tsybalova M., L. Stepanova A., R. Kotlyarov Yu., E. Blokhina A., M. Shuklina A., E. Mardanova S., A. Korotkov V., M. Potapchuk V., N. Ravin V., Л. Цыбалова М., Л. Степанова А., Р. Котляров Ю., Е. Блохина А., М. Шуклина А., Е. Марданова С., А. Коротков В., М. Потапчук В., Н. Равин В.

المصدر: Epidemiology and Vaccinal Prevention; Том 16, № 3 (2017); 65-70 ; Эпидемиология и Вакцинопрофилактика; Том 16, № 3 (2017); 65-70 ; 2619-0494 ; 2073-3046 ; 10.31631/2073-3046-2017-16-3

مصطلحات موضوعية: грипп, вакцинация, рекомбинантный белок, иммуногенность, протективность, influenza, vaccination, recombinant protein, immunogenicity, protection

وصف الملف: application/pdf

Relation: https://www.epidemvac.ru/jour/article/view/278/279; Sette A., Rappuoli R. Reverse vaccinology: Devecoping vaccines in the Era of Genomicsa. Immunity. 2010; 33 (4): 530 - 541.; Ebrahimi S., Tebianian M. Influenza A viruses: why focusing on M2e-based universal vaccines. Virus Genes. 2011; 42: 1 - 8.; Fiers W., De Filette M., El Bakkouri K., Schepens B. et al. M2e-based universal influenza A vaccine. Vaccine. 2009; 27: 6280 - 6283.; Stepanova L., Kotlyarov R., Kovaleva A., Potapchuk M., Sergeeva M., Tsybalova L. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin. PLoS ONE. 2015; 10 (3): 22.; Wang L., Hess A., Chang T., Wang Y. Wang Y.C., Champion J.A., Compans R.W. et al. Nanoclusters self-assembled from conformation-stabilized influenza m2e as broadly cross-protective influenza vaccines. Nanomedicine. 2013; 10: 473 - 482.; Schotsaert M., De Filette M., Fiers W., Saelens X. Universal m2 ectodomain-based influenza a vaccines: Preclinical and clinical developments. Expert Rev. Vaccine. 2009; 8: 499 - 508.; Turley C., Rupp R., Johnson C., Taylor D., Wolfson J. et al. Safety and immunogenicity of a recombinant m2e-flagellin influenza vaccine (stf2.4xm2e) in healthy adults. Vaccine. 2011; 29: 5145-5152.; Wang, T., Tan, G., Hai R., Pica N., Ngai L., Ekiert D.C.et al. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc. Natl. Acad. Sci. USA. 2010; 107: 18979 - 18984.; Corti D., Suguitan A., Pinna D., Silacci C., Fernandez-Rodriguez B.M., Vanzetta F. et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 2010; 120: 1663 - 1673.; Zang H., Wang L., Compans R., Wang B. Universal Influenza Vaccines, a Dream to Be Realized Soon. Viruses. 2014; 6 (5): 1974 - 1991.; Steel J., Lowen A., Wang T., Yondola M. Gao Q,, Haye K, et al. Influenza virus vaccine based on the conserved haemagglutinin stalk domain. MBio. 2010; 1: 1 - 9.; Zhou L., Ren R., Yang L., Bao C., Wu J., Wang D. et al. Sudden increase in human infection with avian influenza A(H7N9) virus in China, Semptember-December 2016 Western Pac Surveill Response J. 2017; 8 (1): 1 - 9.; Ekiert D., Friesen R., Bhabha G., Kwaks T., Jongeneelen M., Yu W. et al. A highly conserved neutralizing epitope on group 2 influenza a viruses. Science. 2011; 333: 843 - 850.; Gocnik M., Fislova T., Mucha V., Sladkova T. et al. J. of General virology. 2008; 89: 958 - 967.; Tsybalova L., Stepanova L., Kuprianov V., Blokhina E., Potapchuk M., Korotkov A. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e. Vaccine. 2015; 05: 3398 - 3406.; Bates J., Aaron H., James P., Jason M. Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88. J. Immunol. 2011; 186 (11):6255 - 62.; Jegerlehner N., Schmitz T., Storni M., Bachmann J. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J. Immunol. 2004; 172: 5598 - 5605.; https://www.epidemvac.ru/jour/article/view/278

الاتاحة: https://www.epidemvac.ru/jour/article/view/278
https://doi.org/10.31631/2073-3046-2017-16-3-65-70

المؤلفون: L. Stepanova, Yu. Karpenko, M. Logvyn

المصدر: Galic'kij ekonomičnij visnik. 70:22-32

مصطلحات موضوعية: Civil society, Political science, Context (language use), Public administration, Tourism

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bb1373ae1d2158ea408ee8491a888045
https://doi.org/10.33108/galicianvisnyk_tntu2021.03.022

المؤلفون: Olga I. Ignatieva, N. V. Moroshkina, V. L. Stepanova, M. I. Badmaeva, V. I. Larionova, O. A. Berkovich, Ольга Игоревна Игнатьева, Надежда Викторовна Морошкина, Валентина Леонидовна Степанова, Мария Ивановна Бадмаева, Валентина Ильинична Ларионова, Ольга Александровна Беркович

المصدر: Translational Medicine; № 2 (2014); 39-46 ; Трансляционная медицина; № 2 (2014); 39-46 ; 2410-5155 ; 2311-4495 ; 10.18705/2311-4495-2014-0-2

مصطلحات موضوعية: S19W polymorphism, инфаркт миокарда, аполипопротеин АV, S19W полиморфизм, полиморфизм генов, Lipid metabolism, myocardial infarction, apolipoprotein AV

وصف الملف: application/pdf

Relation: https://transmed.almazovcentre.ru/jour/article/view/22/23; Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of populationbased prospective studies // J. Cardiovasc. Risk. -1996. - № 3. - P. 213-219.; Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor // Am. J. Cardiol. - 2000. - № 86. - P. 943-949.; Forrester J.S. Triglycerides: risk factor or fellow traveler? // Curr. Opin. Cardiol. - 2001. - № 16. - P. 261-264.; Wang Q. Molecular genetics of coronary artery disease // Curr. Opin. Cardiol. - 2005. - № 20. - P. 182-188.; Chandak G.R., Ward K.J., Yajnik C.S. et al. Triglyce-ride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India, compared to Europeans // BMC Med. Genet. - 2006. - № 7. - P. 76.; Hamon S.C., Kardia S.L., Boerwinkle E. et al. Evidence for consistent intragenic and intergenic interactions between SNP effects in the ApoAI/CIII/AIV/AV gene cluster // Hum. Hered. - 2006. - Vol. 61, № 2. - P. 87-96.; Karathanasis S. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes // Proc. Natl. Acad. Sci. USA. - 1985. - Vol. 82, № 19. - P. 6374-6378.; Groenendijk M., Cantor R.M., Funke H. et al. Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia // Eur. J. Clin. Invest. - 2001. - Vol. 31, № 10. - P. 852-859.; Delgado-Lista J., Perez-Jimenez F., Ruano J. et al. Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men // J. Lipid. Res. - 2010. - Vol. 51, № 1. - P. 63-73.; Pennacchio L.A., Olivier M., Hubacek J.A. et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing // Science. - 2001. - Vol. 294, № 5540. - P. 169-173.; Pennacchio L.A., Olivier M., Hubacek J.A. et al. Two independent apolipoprotein AV haplotypes influence human plasma triglyceride levels // Hum. Mol. Genet. - 2002. - Vol. 11, № 24. - P. 3031-3038.; Henneman P., Schaap F.G., Havekes L.M. et al. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism // Atherosclerosis. - 2007. - Vol. 193, № 1. - P. 129-134.; Lai C.Q., Demissie S., Cupples L.A. et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study // J. Lipid Res. - 2004. - Vol. 45. - P. 2096-2105.; Talmud P.J., Martin S., Taskinen M.-R. Apo AV gene variants, lipoprotein particle distribution, and progression coronary heart disease: results from the LOCAT study // J. Lip. Res. - 2004. - Vol. 45. - P. 750-756.; Ding Y., Zhu M.A., Wang Z.X. et al. Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome // Biomed. Biotech-nol. - 2012. - 509420.; Hubacek J.A., Skodova Z., Adamkova V. et al. The influence of APOAV polymorphisms (T-1131 > C and S19 > W) on plasma triglyceride levels and risk of myocardial infarction // Clin. Genet. - 2004. - Vol. 65. - P. 126-130.; Dallongeville J., Cottel D., Montaye M. et al. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men // Int. J. Cardiol. - 2006. - Vol. 106. - P. 152-156.; Martinelli N., Trabetti E., Bassi A. et al. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study // Atherosclerosis. - 2007. - Vol. 191. - P. 409-417.; Prochaska C.L., Picheth G., Anghebem-Oliveira M.I. The polymorphisms -1131T>C and the S19W of the APOA5 gene are not associated with coronary artery disease in a Brazilian population // Clin. Chem. Lab. Med. - 2010. - Vol. 48. - P. 419-422.; Климов А.Н., Ганелина И.Е. Фенотипирование гиперлипидемий // М.: Медицина, 1975. - C. 47.; Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge // Clin. Chem. - 1972. - Vol. 18, № 6. - P. 499-502.; Kunkel L.M., Smith K.D., Boyer S.H. et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants // Proc. Natl. Acad. Sci. USA. - 1977. - Vol. 74, № 3. - P. 1245-1249.; Lahiri D.K., Bye S., Nurberger J.I. et al. A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested // J. Biochem. Biophys. Methods. - 1992. - Vol. 25, № 4. - P. 193-205.; Talmud P.J., Hawe E., Martin S. et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides // Hum. Mol. Genet. - 2002. - Vol. 11, № 24. - P. 3039-3046.; Zhang Z., Peng B., Gong R. et al. Apolipoprotein A5 polymorphisms and risk of coronary artery disease: a meta-analysis // BioScience Trends. - 2011. - Vol. 5, № 4. - P. 165-172.; Guardiola M., Ribalta J., Gómez-Coronado D. et al. The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study) // Atherosclerosis. - 2010. - Vol. 212, № 2. - P. 543-547.; Evans D., Bode A., von der Lippe G. et al. Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation In the apolipoprotein A5 gene // Eur. J. Med. Res. - 2011. - Vol. 16. - P. 79-84.; Perez-Martinez P., Corella D., Shen J. et al. Associaton between glukinase protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states // Am. J. Clin. Nutr. - 2009. - Vol. 89. - P. 391399.; Sóter M.O., Gomes K.B., Fernandes A.P. et al. -1131T > C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients // Mol. Biol. Rep. - 2012. - Vol. 39, № 7. - P. 7541-7548.; Gesteiro E., Bastida S., Vázquez-Velasco M. et al. Effects of APOA5 S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates // Eur. J. Pediatr. - 2011. - Vol. 170, № 12. - P. 1551-1558.; https://transmed.almazovcentre.ru/jour/article/view/22

الاتاحة: https://transmed.almazovcentre.ru/jour/article/view/22
https://doi.org/10.18705/2311-4495-2014-0-2-39-46

المؤلفون: Tetyana Beregova, Yu. Tseysler, T. Kondratiuk, L. Stepanova, V. Martyniuk

المصدر: Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology. 83:6-10

مصطلحات موضوعية: Antioxidant, Chromatography, Membrane permeability, Chemistry, medicine.medical_treatment, 010401 analytical chemistry, Biological activity, General Medicine, 01 natural sciences, Blood proteins, 0104 chemical sciences, Melanin, Solvent, 03 medical and health sciences, 0302 clinical medicine, Blood serum, medicine, sense organs, Solubility, 030217 neurology & neurosurgery

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0ed248ef7c1af73e7dd0f39f4acec744
https://doi.org/10.17721/1728_2748.2020.83.6-10

المؤلفون: L. G. Teslenko, S. V. Sharov, R. A. Murashko, S.A. Yargunin, M.G. Leonov, L. L. Stepanova, K.A. Babanskaya

المصدر: Effective Pharmacotherapy. 15:6-11

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Medicine, Disease, Skin melanoma, business, Dermatology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2c4cdef53d91f59683c7fba694a26806
https://doi.org/10.33978/2307-3586-2019-15-24-6-11